Multiple Drug Therapy for COVID-19

"The 8 sites for this trial are situated in Golden, Minneapolis, Sylmar and other locations. To cut down on participant burden, it is best to select a location nearest to you."

"This study will assess the primary outcome of emergency department utilization over a 14-day period. Secondary outcomes include laboratory outcome subsidy - CRP (self-collected finger stick blood), change in CRP between baseline and follow-up, post-acute sequelae of SARS-CoV-2 infection (PASC) questionnaire, clinical progression scale, and percentage of participants who report PASC any symptoms."

"Metformin is most often used to treat strongyloidiasis, which is caused by the infection of Strongyloides stercoralis. However, it is also effective in treating a number of other conditions such as obsessive-compulsive disorder and gnathostomiasis."

"This particular trial is no longer recruiting patients. The study was originally posted on January first 2021 but the most recent edit occurred on August fifth, 2022. There are presently 1859 trials actively enrolling patients with infections and 205 studies for Metformin that are still looking for research candidates."

"Metformin has been given a safety score of three. This is based on the fact that it is a Phase 3 trial, which suggests that not only is there some evidence of its efficacy, but also that multiple rounds of testing have confirmed its safety."

"Based on the given information, this trial is for patients aged between 30-85. Out of the 379 clinical trials available for people under 18 and 1708 trials catered to those over 65, this one looks specifically at a middle-aged population."

"This study is admitting 1350 patients with infections aged 30 and 85. Most notable, candidates should meet the following criteria: Positive laboratory test for active SARS-CoV-2 viral infection based on local laboratory standard (i.e. +PCR) within 3 days of randomization., No known history of confirmed SARS-CoV-2 infection, BMI >= 25kg/m2 by self-report height/weight or >= 23kg/m2 in patients who self-identify in South Asian or Latinx background., Willing and able to comply with study procedures (i.e. swallow pills),"

"According to the information available on clinicaltrials.gov, this particular trial is no longer actively recruiting patients. The first posting was on January 1st, 2021 and the most recent edit was on August 5th, 2022. There are 2064 other trials that are still looking for patients."

"There are currently 205 ongoing studies researching Metformin. 59 of those live studies are in Phase 3, meaning they have completed multiple rounds of data collection supporting efficacy and safety. While the many studies for Metformin are based in Nova Lima, MG, there are 2476 locations running clinical trials for this treatment worldwide."